With the analysis among 193 patents, we discovered top 39 key players by total patent application. Novavax, Inc., Eurocine Vaccines AB, Trellis Bioscience, Inc. are dominant in this area. They take 43.52% of the total patent filing.
STOCKHOLM, Sweden
Patent: 27
California, United States
Patent: 24
Maharashtra, India
Patent: 11
New York, United States
Patent: 8
Zuid-Holland, Netherlands
Patent: 7
California, United States
Patent: 7
Basel-Stadt, Switzerland
Patent: 5
No data, please try another search term
With the analysis among related 70 patents applied in the last 5 years. We discover 23 most active companies in this area. The fast-growing Serum Institute of India Pvt Ltd., Denka Corp., Janssen Vaccines & Prevention BV take 37.14% of patent filing during this period.
Maharashtra, India
Patent: 11
New York, United States
Patent: 8
Zuid-Holland, Netherlands
Patent: 7
Illinois, United States
Patent: 5
undefined undefined
Patent: 4
undefined undefined
Patent: 3
Massachusetts, United States
Patent: 3
With the analysis among related 70 patents in last 5 years, we discover 20 new entrants. Serum Institute of India Pvt Ltd., Denka Corp., Janssen Vaccines & Prevention BV are the most active new entrants in this area.
Maharashtra, India
Patent: 11
New York, United States
Patent: 8
Zuid-Holland, Netherlands
Patent: 7
Illinois, United States
Patent: 5
undefined undefined
Patent: 4
undefined undefined
Patent: 3
Massachusetts, United States
Patent: 3
Andhra Pradesh, India
Patent: 2
With the analysis among 30 patents, we discovered top 10 universities and scientific research institutions by total patent application. Sun Yat-Sen University, University of Hong Kong, Fudan University are dominant in this area. They take 30.00% of the total patent filing.
Guangdong Sheng, China
Patent: 2
Hong Kong SAR, China
Patent: 1
Shanghai Shi, China
Patent: 1
CITY OF CENTRAL, Sri Lanka
Patent: 1
Guangdong Sheng, China
Patent: 1
Nuevo León, Mexico
Patent: 1
Sichuan Sheng, China
Patent: 1
Xizang Zizhiqu, China
Patent: 1
Beijing Shi, China
Patent: 1